SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-045373
Filing Date
2024-05-21
Accepted
2024-05-21 07:40:11
Documents
2
Period of Report
2024-05-21

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0206609-6k_purplebio.htm 6-K 14437
2 PURPLE BIOTECH REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS ea020660901ex99-1_purplebio.htm EX-99.1 116755
  Complete submission text file 0001213900-24-045373.txt   132468
Mailing Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104
Business Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 97239333121
PURPLE BIOTECH LTD. (Filer) CIK: 0001614744 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37643 | Film No.: 24966846
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)